GIANCANE, GABRIELLA
 Distribuzione geografica
Continente #
EU - Europa 3.732
AS - Asia 457
NA - Nord America 281
SA - Sud America 36
AF - Africa 11
Totale 4.517
Nazione #
IT - Italia 3.650
US - Stati Uniti d'America 257
SG - Singapore 188
CN - Cina 115
VN - Vietnam 82
FR - Francia 33
BR - Brasile 23
HK - Hong Kong 20
BD - Bangladesh 16
DE - Germania 16
CA - Canada 13
GB - Regno Unito 8
IN - India 8
JP - Giappone 5
ZA - Sudafrica 5
AR - Argentina 4
IQ - Iraq 4
MX - Messico 4
CO - Colombia 3
DO - Repubblica Dominicana 3
FI - Finlandia 3
NL - Olanda 3
PK - Pakistan 3
RO - Romania 3
RU - Federazione Russa 3
UA - Ucraina 3
AM - Armenia 2
AT - Austria 2
EC - Ecuador 2
ID - Indonesia 2
MA - Marocco 2
PH - Filippine 2
TR - Turchia 2
VE - Venezuela 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.517
Città #
Genova 1.878
Genoa 1.071
Rapallo 362
Vado Ligure 303
Singapore 94
San Jose 81
Lauterbourg 30
Beijing 22
New York 21
Ashburn 20
Ho Chi Minh City 19
Hong Kong 19
Council Bluffs 16
Hanoi 16
Haiphong 8
Frankfurt am Main 6
Santa Clara 6
Bordighera 5
Chicago 5
Montreal 5
Berlin 4
Chennai 4
Da Nang 4
Los Angeles 4
Milan 4
Orem 4
Tokyo 4
Vedano Olona 4
Biên Hòa 3
Buffalo 3
Dallas 3
Kyiv 3
Mexico City 3
Piscataway 3
Rome 3
Santo Domingo 3
São Paulo 3
Thái Bình 3
Tianjin 3
Acalanes Ridge 2
Agadir 2
Amsterdam 2
Boston 2
Can Tho 2
Changsha 2
City of London 2
Helsinki 2
Islamabad 2
Johannesburg 2
Leipzig 2
Moscow 2
Naples 2
Nuremberg 2
Pittsburgh 2
Rosarno 2
San Francisco 2
Shanghai 2
Toronto 2
Addis Ababa 1
Alagoinhas 1
Ancona 1
Antioch 1
Araçoiaba 1
Arlington 1
Baghdad 1
Baltimore 1
Bangkok 1
Banyuwangi 1
Barueri 1
Basingstoke 1
Basra 1
Belleville 1
Bengaluru 1
Benito Juarez 1
Blackburn 1
Blumenau 1
Bogotá 1
Bucharest 1
Bắc Giang 1
Cachoeiras de Macacu 1
Cadiz 1
Cajamarca 1
Calgary 1
Campo Limpo Paulista 1
Canary Wharf 1
Cape Town 1
Caracas 1
Cascavel 1
Chesapeake 1
Columbia City 1
Crestview 1
Dakar 1
Dammam 1
Dasmariñas 1
Delaware 1
Delmar 1
Denver 1
Des Moines 1
Dublin 1
Dubnica nad Váhom 1
Totale 4.132
Nome #
Juvenile Idiopathic Arthritis: Diagnosis and Treatment 218
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 194
Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis. 184
Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry 183
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 182
Clinical outcome measures in juvenile idiopathic arthritis 176
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases 171
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 163
Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era 161
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever 157
Recent therapeutic advances in juvenile idiopathic arthritis 156
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 156
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 154
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 154
EULAR recommendations for the management of familial Mediterranean fever 153
Temporomandibular joint involvement in juvenile idiopathic arthritis: Reliability and validity of a screening protocol for the rheumatologist 148
Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. 145
Update on the pathogenesis and treatment of juvenile idiopathic arthritis 145
Primary hypertrophic osteoarthropathy: An update on patient features and treatment 128
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 127
Information technology in paediatric rheumatology 122
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 121
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 119
Treatment of juvenile idiopathic arthritis: what's new? 118
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 118
Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? 110
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 109
The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis 103
Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study 100
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis 97
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 96
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis 94
Outcome Scores in Pediatric Rheumatology 54
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 32
Totale 4.648
Categoria #
all - tutte 16.381
article - articoli 15.911
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022400 14 12 18 32 14 38 15 79 43 51 20 64
2022/2023424 35 40 8 40 84 60 1 34 71 1 45 5
2023/2024243 17 32 4 39 21 18 19 14 16 11 10 42
2024/2025774 32 50 34 60 70 71 78 158 23 42 85 71
2025/20261.205 201 27 50 53 181 94 183 41 89 148 77 61
Totale 4.648